Transporter-Mediated Uptake of UDP–Glucuronic Acid by Human Liver Microsomes: Assay Conditions, Kinetics, and Inhibition
Open Access
- 1 January 2015
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 43 (1) , 147-153
Abstract
This study characterized the kinetics, variability and factors that affect UDP-glucuronic acid (UDP-GlcUA) uptake by human liver microsomes (HLM). Biphasic kinetics were observed for UDP-GlcUA uptake by HLM. Uptake affinities (assessed as Kd) of the high- and low- affinity components differed by more than an order of magnitude (13±6μM versus 374±175μM), but were comparable in terms of the maximal rate of uptake with mean Vmax values differing less than 2.3-fold (56±26pmol/min/mg versus 131±35pmol/min/mg). Variability in total intrinsic transporter activity (Uint) for microsomal UDP-GlcUA uptake across 12 livers was less than 4-fold. Experiments performed to optimize the conditions for microsomal UDP-GlcUA uptake demonstrated that both components were trans-stimulated by pre-loading (luminal addition) with an alternate UDP-sugar, and essentially abolished by the thiol-alkylating agent N-ethylmaleimide. Furthermore, interaction studies undertaken with a panel of drugs, alternate UDP-sugars and glucuronide conjugates, at low- (2.5μM) and high- (1000μM) UDP-GlcUA concentrations, demonstrated that both components were inhibited to varying extents. Notably, the nucleoside analogs zidovudine, stavudine, lamivudine and acyclovir inhibited both the high- and low- affinity components of microsomal UDP-GlcUA uptake by >45% at an inhibitor concentration of 100μM. Taken together, these data demonstrate that human liver microsomal UDP-GlcUA uptake involves multiple protein-mediated components, and raises the possibility of impaired in vivo glucuronidation activity resulting from inhibition of UDP-GlcUA uptake into the ER membrane by drugs and other compounds.Keywords
This publication has 33 references indexed in Scilit:
- Functional UDP-xylose Transport across the Endoplasmic Reticulum/Golgi Membrane in a Chinese Hamster Ovary Cell Mutant Defective in UDP-xylose SynthaseJournal of Biological Chemistry, 2009
- The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 ActivitiesDrug Metabolism and Disposition, 2008
- Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) familyBiochemical Journal, 2006
- The Importance of Local Chemical Structure for Chemical Metabolism by Human Uridine 5‘-Diphosphate−GlucuronosyltransferaseJournal of Chemical Information and Modeling, 2006
- S‐Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP‐glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxenBritish Journal of Clinical Pharmacology, 2005
- Predicting Human Drug Glucuronidation Parameters: Application of In Vitro and In Silico Modeling ApproachesAnnual Review of Pharmacology and Toxicology, 2004
- Two kinetically-distinct components of UDP-glucuronic acid transport in rat liver endoplasmic reticulumBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Specificity of human UDP-Glucuronosyltransferases and xenobiotic glucuronidationLife Sciences, 1995
- Functional characterization of carrier‐mediated transport of uridine diphosphate N‐acetylglucosamine across the endoplasmic reticulum membraneEuropean Journal of Biochemistry, 1994
- THE SARCOPLASMIC RETICULUM OF STRIPED MUSCLEJournal of Cell Biology, 1956